<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> (aPL) are thrombophilic risk markers in patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) or <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>The risk factors for recurrent venous or <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> and indications for longterm anticoagulation therapy are debated </plain></SENT>
<SENT sid="2" pm="."><plain>We hypothesized that carrying a second thrombophilic defect, <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e>, would increase the risk for <z:mp ids='MP_0005048'>thrombosis</z:mp> in patients with aPL </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Seventy-five patients with primary APS and 83 with SLE and aPL with or without <z:mp ids='MP_0005048'>thrombosis</z:mp> followed at 2 university hospitals were studied </plain></SENT>
<SENT sid="4" pm="."><plain>Factor V mutation rate was analyzed in patients and in 200 healthy blood donors by polymerase chain reaction analysis </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The prevalence of <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e> in patients with SLE and aPL or primary APS was similar to controls </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with <z:hpo ids='HP_0002625'>deep vein thrombosis</z:hpo> or <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> did not have a significantly increased rate of factor V mutation compared to controls or to patients with aPL without <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">Factor V Leiden mutation</z:e> is not significantly associated with vein <z:mp ids='MP_0005048'>thrombosis</z:mp> in patients with aPL </plain></SENT>
<SENT sid="8" pm="."><plain>However, due to the sample size we cannot rule out synergy between both factor V Leiden and aPL </plain></SENT>
<SENT sid="9" pm="."><plain>A trend toward increased risk for <z:mp ids='MP_0005048'>thrombosis</z:mp> was detected in patients with the mutation and this should be analyzed in a larger study </plain></SENT>
</text></document>